| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 1371466 | Bioorganic & Medicinal Chemistry Letters | 2011 | 4 Pages | 
The neurokinin-3 (NK3) receptor is regarded as a potential novel target for treating patients with schizophrenia. Herein we report the synthesis and SAR of a series of C3-alkylsulfoxide substituted quinolines as potent NK3 receptor antagonists. These compounds have excellent NK3 functional activity, good selectivity and drug-like properties. Several key compounds have good in vitro/in vivo DMPK characteristics, and are active in a gerbil locomotor activity model.
Graphical abstractSynthesis and SAR of a series of C3-alkylsulfoxide substituted quinolines as potent NK3 receptor antagonists are reported. These compounds have excellent NK3 functional activity, good selectivity and drug-like properties. Several key compounds have good in vitro/in vivo DMPK characteristics, and are active in a gerbil locomotor activity model.Figure optionsDownload full-size imageDownload as PowerPoint slide
